Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 471 | 2023 |
Trifluridine–tipiracil and bevacizumab in refractory metastatic colorectal cancer GW Prager, J Taieb, M Fakih, F Ciardiello, E Van Cutsem, E Elez, ... New England Journal of Medicine 388 (18), 1657-1667, 2023 | 227 | 2023 |
Tratado de oncologia PMG Hoff Atheneu, 2013 | 112 | 2013 |
Pathology of anal cancer PM Hoff, R Coudry, CMV Moniz Surgical Oncology Clinics 26 (1), 57-71, 2017 | 84 | 2017 |
Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with localized squamous cell carcinoma of the anal canal SCR Oliveira, CMV Moniz, R Riechelmann, AK Alex, MI Braghirolli, ... Journal of gastrointestinal cancer 47, 75-81, 2016 | 63 | 2016 |
Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil MC Maroja Silvino, CM Venchiarutti Moniz, GH Munhoz Piotto, S Siqueira, ... Rare Tumors 5 (3), 149-151, 2013 | 36 | 2013 |
Sympathetic neural overdrive, aortic stiffening, endothelial dysfunction, and impaired exercise capacity in severe COVID-19 survivors: a mid-term study of cardiovascular sequelae D Faria, RJ Moll-Bernardes, L Testa, CMV Moniz, EC Rodrigues, ... Hypertension 80 (2), 470-481, 2023 | 32 | 2023 |
Câncer e Doenças Cardiovasculares na pandemia de Covid-19 LT Kawahara, IBSS Costa, CCS Barros, GC Almeida, CS Bittar, SI Rizk, ... Arquivos Brasileiros de Cardiologia 115, 547-557, 2020 | 29 | 2020 |
Outcomes and prognostic factors in a large cohort of hospitalized cancer patients with COVID-19 G Nader Marta, R Colombo Bonadio, O Nicole Encinas Sejas, G Watarai, ... JCO Global Oncology 7, 1084-1092, 2021 | 21 | 2021 |
How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center ATC Chen, CMV Moniz, U Ribeiro-Junior, MDPE Diz, JV Salvajoli, ... Clinics 75, e1864, 2020 | 21 | 2020 |
Cancer and cardiovascular diseases during the COVID-19 pandemic LT Kawahara, IBSS Costa, CCS Barros, GC Almeida, CS Bittar, SI Rizk, ... Arquivos Brasileiros de Cardiologia 115, 547-557, 2020 | 10 | 2020 |
Biomarkers in anal cancer: current status in diagnosis, disease progression and therapeutic strategies MC Mathias-Machado, RDA Peixoto, CMV Moniz, AA Jácome Biomedicines 10 (8), 2029, 2022 | 7 | 2022 |
Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors D Faria, R Moll-Bernardes, L Testa, CMV Moniz, EC Rodrigues, JM Mota, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2023 | 6 | 2023 |
Intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis: study protocol of a phase ii trial MFKP Ramos, MA Pereira, AZ Charruf, CR Victor, JVAM Gregorio, ... ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 36, e1744, 2023 | 6 | 2023 |
Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy. H Araujo, CMV Moniz, OFM Braghiroli, MP Mak, LF Uratani, ... Journal of Clinical Oncology 39 (15_suppl), 2652-2652, 2021 | 6 | 2021 |
A prospective cohort study of biomarkers in squamous cell carcinoma of the Anal Canal (SCCAC) and their influence on treatment outcomes CMV Moniz, RP Riechelmann, SCR Oliveira, GM Bariani, TG Rivelli, ... Journal of Cancer 12 (23), 7018, 2021 | 6 | 2021 |
Anal canal cancers, an issue of surgical oncology clinics of North America C Eng Elsevier Health Sciences 26 (1), 2016 | 4 | 2016 |
Real-world data for high-risk stage ii colorectal cancer–The role of tumor side in the adjuvant setting CS Araujo, CMV Moniz, RC Bonadio, GY Watarai, J Rojas, PVS Nogueira, ... Clinical Colorectal Cancer 20 (2), e100-e108, 2021 | 3 | 2021 |
Prospective study of biomarkers in squamous cell carcinoma of the anal canal (SCCAC) and their influence on treatment outcomes: Final results. CMV Moniz, RP Riechelmann, SC Ribeiro, TG Rivelli, GM Bariani, ... Journal of Clinical Oncology 35 (15_suppl), 3577-3577, 2017 | 3 | 2017 |
Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients R Barroso-Sousa, RR Munhoz, MP Mak, LG Fonseca, ABS Fede, ... International braz j urol 40 (6), 835-841, 2014 | 3 | 2014 |